Last $2.29 USD
Change Today +0.07 / 3.15%
Volume 328.3K
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:30 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James M. Gower

Former Executive Officer, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

65$1,709,874
As of Fiscal Year 2013

Background*

Mr. James M. Gower serves as an Advisor of VantagePoint Venture Partners. Mr. Gower served as the Chief Executive Officer of Rigel Pharmaceuticals, Inc. from January 1997 and as its Chairman from October 2001 to November 2014. He served as President at Rigel Pharmaceuticals, Inc., since January 1997. From 1992 to March 1996, he served as the President and Chief Executive Officer of Tularik, Inc. He held several positions with Genentech, Inc., as Senior Vice President, ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

1996-N/A
Former Director
1997-2014
Former Executive Officer

Education*

BS
University of Tennessee System, The
MBA
University of Tennessee System, The

Other Affiliations*

Annual Compensation*

Salary$695,118
Total Annual Compensation$695,118

Stock Options*

All Other Compensation$9,906
Exercisable Options1,423,125
Unexercisable Options121,875
Total Number of Options1,545,000

Total Compensation*

Total Annual Cash Compensation$705,024
Total Short Term Compensation$695,118
Other Long Term Compensation$9,906
Total Calculated Compensation$1,709,874
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.29 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.